Exploring the gut bacteria in newborn infants
Official title: Recovery of a Probiotic in Term Newborns - a Randomized, Double-blinded, Placebo-controlled Proof-of-concept Study
Run by Hvidovre University Hospital · NCT06789484 · Data updated 2026-11-12
This study tests if giving a specific probiotic to healthy newborns for four weeks can help improve their gut bacteria.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 1 Day |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Hvidovre University Hospital Academic / other |
| Locations | 1 site (Hvidovre) |
| Status | Recruiting |
| Started | March 4, 2025 |
| Main results expected | October 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | April 13, 2025 |
| Trial ID | NCT06789484 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy pregnant individuals in their late third trimester planning to exclusively breastfeed and their full-term newborns.
✕Probably not a fit
Patients with congenital disorders or those not meeting the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the gastrointestinal microbiota in healthy newborn infants by supplementing them with a specific probiotic strain for four weeks. It is a randomized, double-blinded, placebo-controlled trial conducted at Hvidovre University Hospital. The primary goal is to assess how well the probiotic strain can establish itself in the infants' gut, measured through fecal samples analyzed with quantitative Polymerase Chain Reaction (qPCR). Following the intervention, there will be a two-week follow-up period to monitor the effects.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of infant gut health and potentially improve dietary recommendations for newborns.
How similar studies have gone: Previous studies on probiotics in infants have shown promising results, indicating potential benefits in gut health, making this approach both relevant and supported by existing literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Inclusion Criteria for the pregnant person:
1. Healthy pregnant person in gestational week 36+0-38+0
2. Age ≥ 18 years
3. Normal singleton pregnancy
4. Ability to read and speak Danish
5. Normal ultrasound scan of the fetus at gestational age 19-20 weeks
6. Plan to exclusively breastfeed
7. Provided voluntary written informed consent.
* Inclusions Criteria for the newborn:
1. Born at full-term ≥37+0
2. Birth weight above 2500 g
3. APGAR score of at least 7 within the first 5 min of life.
Exclusion Criteria:
* Exclusion Criteria for the pregnant person:
1. Pregnancy at over 38+0 weeks' gestation at recruitment
2. Multiple pregnancy
3. Pregnancy with any fetal abnormality
4. Alcohol or drug abuse
5. Plan to give birth at other hospitals than Copenhagen University Hospital Hvidovre
6. Any contraindications for breastfeeding.
Exclusion Criteria for the newborn :
1. Congenital disorders that could affect their safety or the study outcome
2. Admission to Neonatal Intensive Care Unit for more than 24 hours
3. Participation in another clinical intervention study which can interfere with this probiotic intervention
4. No other probiotics than the study product.
Where it's running
-
Center for Klinisk Mikrobiom Forskning, Gastroenheden og Klinisk Mikrobiologisk Afdeling
Hvidovre, Denmark Recruiting
Study contacts
- Principal investigator: Andreas Munk Petersen, MD, PhD, DMSc — Center for Klinisk Mikrobiom Forskning, Gastroenheden og Klinisk Mikrobiologisk Afdeling, Hvidovre Hospital
- Study coordinator: Sofie Ingdam Halkjær, MSc, PhD
- Email: sofie.ingdam.halkjaer@regionh.dk
- Phone: +4541318174
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotic supplement in healthy infants to study gut microbiota and immune function
Giving a probiotic to healthy infants from birth up to 6 months old to see how it affects their gut bacteria and immune health.
-
Growth, tolerance, and gut markers in healthy infants given dietary supplements
This study tests whether giving probiotic supplements to healthy newborns helps with weight gain and gut health compared with a placebo.
-
Preventing excessive crying and colic in newborns with a probiotic supplement of two L. reuteri strains
This will try giving healthy newborns a dietary supplement containing two L. reuteri probiotic strains plus vitamin D during their first three months to see if it reduces excessive crying and infantile colic compared with a placebo.
-
Dietary supplement in healthy infants
A double-blind, placebo-controlled study is testing whether a dietary supplement given to healthy term infants can change their gut microbiome compared with a placebo.
-
Effect of a New Infant Formula on Gut Health in Healthy Infants
A healthy, full-term infant formula is tested to see if it increases the good gut bacteria (Bifidobacterium) after 10 weeks compared with a standard formula.
-
Daily probiotic supplement for healthy newborns
We're testing whether giving a daily probiotic to healthy newborns from about two weeks to nine months helps their gut microbiome and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.